{"id":83785,"date":"2023-08-17T13:47:27","date_gmt":"2023-08-17T17:47:27","guid":{"rendered":"https:\/\/wfh.org\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/"},"modified":"2024-04-08T08:34:39","modified_gmt":"2024-04-08T12:34:39","slug":"remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis","status":"publish","type":"post","link":"https:\/\/wfh.org\/fr\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/","title":{"rendered":"Remplacement des dispositifs de reconstitution BAXJECT II \/ BAXJECT II Hi-Flow co-emball\u00e9s avec Advate\/Feiba\/Rixubis"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"83785\" class=\"elementor elementor-83785 elementor-82437\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-fefea6e elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"fefea6e\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-9186313\" data-id=\"9186313\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-2354f40 elementor-widget elementor-widget-text-editor\" data-id=\"2354f40\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.23.0 - 25-07-2024 *\/\n.elementor-widget-text-editor.elementor-drop-cap-view-stacked .elementor-drop-cap{background-color:#69727d;color:#fff}.elementor-widget-text-editor.elementor-drop-cap-view-framed .elementor-drop-cap{color:#69727d;border:3px solid;background-color:transparent}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap{margin-top:8px}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap-letter{width:1em;height:1em}.elementor-widget-text-editor .elementor-drop-cap{float:left;text-align:center;line-height:1;font-size:50px}.elementor-widget-text-editor .elementor-drop-cap-letter{display:inline-block}<\/style>\t\t\t\t<p>Takeda a identifi\u00e9 les pays qui ont re\u00e7u les lots concern\u00e9s et travaille avec les autorit\u00e9s de sant\u00e9 r\u00e9gionales, nationales et locales pour mettre en place des actions correctives, qui peuvent varier selon les pays. En accord avec l\u2019Agence europ\u00e9enne des m\u00e9dicaments, Takeda va travailler avec les autorit\u00e9s de sant\u00e9 des pays europ\u00e9ens concern\u00e9s pour fournir des remplacements aux dispositifs de reconstitution BAXJECT II et BAXJECT II Hi-Flow aux professionnel\u00b7le\u00b7s de sant\u00e9 ayant re\u00e7u des dispositifs issus des lots touch\u00e9s.<\/p>\n<p>Les dispositifs de reconstitution BAXJECT II et BAXJECT II Hi-Flow contenus dans les lots mentionn\u00e9s dans la liste doivent \u00eatre d\u00e9truits et les dispositifs de remplacement doivent \u00eatre utilis\u00e9s comme indiqu\u00e9 dans l\u2019information produit.<\/p>\n<p>Pour en savoir plus, <a href=\"https:\/\/www.ema.europa.eu\/en\/medicines\/dhpc\/replacement-baxject-ii-baxject-ii-hi-flow-reconstitution-devices-co-packaged-advate-feiba-rixubis#about-section\" target=\"_blank\" rel=\"noopener\">cliquez ici<\/a> (texte en anglais). Pour lire le communiqu\u00e9 publi\u00e9 par Takeda, <a href=\"https:\/\/wfh.org\/wp-content\/uploads\/2023\/08\/Takeda-letter-Replacement-BAXJECT-II.pdf\" target=\"_blank\" rel=\"noopener\">cliquez ici<\/a> (anglais). Pour lire la d\u00e9claration de l\u2019European Haemophilia Consortium, <a href=\"https:\/\/www.ehc.eu\/baxject-ii-baxject-ii-hi-flow-reconstitution-devices\/\" target=\"_blank\" rel=\"noopener\">c\u2019est ici<\/a> (anglais). Pour lire la d\u00e9claration de la National Bleeding Disorders Foundation (NBDF), <a href=\"https:\/\/www.hemophilia.org\/news\/medical-advisory-429-notice-regarding-baxjectr-ii-reconstitution-devices\" target=\"_blank\" rel=\"noopener\">c\u2019est ici<\/a> (en anglais \u00e9galement).<\/p>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Takeda a pris la d\u00e9cision de remplacer les dispositifs de reconstitution BAXJECT II et BAXJECT II Hi-Flow, produits chez son fabricant sous-traitant entre octobre 2021 et 2022. Il s\u2019agit d\u2019une mesure de pr\u00e9caution due \u00e0 la pr\u00e9sence possible de particules au niveau du port Luer. Ce probl\u00e8me est li\u00e9 au dispositif lui-m\u00eame et aucun d\u00e9faut qualit\u00e9 n\u2019affecte le produit th\u00e9rapeutique ou tout autre composant de la bo\u00eete. Aucun effet ind\u00e9sirable signal\u00e9 dans la base de donn\u00e9es de s\u00e9curit\u00e9 de Takeda n\u2019est attribuable \u00e0 la pr\u00e9sence de particules dans les dispositifs BAXJECT II ou BAXJECT II Hi-Flow.<\/p>\n","protected":false},"author":13,"featured_media":52730,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[177],"tags":[],"search-category":[85],"class_list":["post-83785","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualite-medicale","search-category-article"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.4 (Yoast SEO v23.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Remplacement des dispositifs de reconstitution BAXJECT II \/ BAXJECT II Hi-Flow co-emball\u00e9s avec Advate\/Feiba\/Rixubis | FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/wfh.org\/fr\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Remplacement des dispositifs de reconstitution BAXJECT II \/ BAXJECT II Hi-Flow co-emball\u00e9s avec Advate\/Feiba\/Rixubis\" \/>\n<meta property=\"og:description\" content=\"Takeda a pris la d\u00e9cision de remplacer les dispositifs de reconstitution BAXJECT II et BAXJECT II Hi-Flow, produits chez son fabricant sous-traitant entre octobre 2021 et 2022. Il s\u2019agit d\u2019une mesure de pr\u00e9caution due \u00e0 la pr\u00e9sence possible de particules au niveau du port Luer. Ce probl\u00e8me est li\u00e9 au dispositif lui-m\u00eame et aucun d\u00e9faut qualit\u00e9 n\u2019affecte le produit th\u00e9rapeutique ou tout autre composant de la bo\u00eete. Aucun effet ind\u00e9sirable signal\u00e9 dans la base de donn\u00e9es de s\u00e9curit\u00e9 de Takeda n\u2019est attribuable \u00e0 la pr\u00e9sence de particules dans les dispositifs BAXJECT II ou BAXJECT II Hi-Flow.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/wfh.org\/fr\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/\" \/>\n<meta property=\"og:site_name\" content=\"FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/wfhemophilia\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-17T17:47:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-08T12:34:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/12\/Medical-news-header-FR.gif\" \/>\n\t<meta property=\"og:image:width\" content=\"2501\" \/>\n\t<meta property=\"og:image:height\" content=\"1307\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/gif\" \/>\n<meta name=\"author\" content=\"Mitch Semienchuk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mitch Semienchuk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/wfh.org\/fr\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/\"},\"author\":{\"name\":\"Mitch Semienchuk\",\"@id\":\"https:\/\/wfh.org\/fr\/#\/schema\/person\/f57928f0dd0ca8906b81082895256d8f\"},\"headline\":\"Remplacement des dispositifs de reconstitution BAXJECT II \/ BAXJECT II Hi-Flow co-emball\u00e9s avec Advate\/Feiba\/Rixubis\",\"datePublished\":\"2023-08-17T17:47:27+00:00\",\"dateModified\":\"2024-04-08T12:34:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/\"},\"wordCount\":199,\"publisher\":{\"@id\":\"https:\/\/wfh.org\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/12\/Medical-news-header-FR.gif\",\"articleSection\":[\"Actualit\u00e9 m\u00e9dicale\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/wfh.org\/fr\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/\",\"url\":\"https:\/\/wfh.org\/fr\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/\",\"name\":\"Remplacement des dispositifs de reconstitution BAXJECT II \/ BAXJECT II Hi-Flow co-emball\u00e9s avec Advate\/Feiba\/Rixubis | FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie\",\"isPartOf\":{\"@id\":\"https:\/\/wfh.org\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/12\/Medical-news-header-FR.gif\",\"datePublished\":\"2023-08-17T17:47:27+00:00\",\"dateModified\":\"2024-04-08T12:34:39+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/wfh.org\/fr\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/wfh.org\/fr\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/#primaryimage\",\"url\":\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/12\/Medical-news-header-FR.gif\",\"contentUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/12\/Medical-news-header-FR.gif\",\"width\":2501,\"height\":1307,\"caption\":\"logo stock\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/wfh.org\/fr\/#website\",\"url\":\"https:\/\/wfh.org\/fr\/\",\"name\":\"FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie\",\"description\":\"WFH - World Federation of Hemophilia\",\"publisher\":{\"@id\":\"https:\/\/wfh.org\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/wfh.org\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/wfh.org\/fr\/#organization\",\"name\":\"World Federation of Hemophilia\",\"url\":\"https:\/\/wfh.org\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/wfh.org\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg\",\"contentUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg\",\"width\":210,\"height\":63,\"caption\":\"World Federation of Hemophilia\"},\"image\":{\"@id\":\"https:\/\/wfh.org\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/wfhemophilia\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/wfh.org\/fr\/#\/schema\/person\/f57928f0dd0ca8906b81082895256d8f\",\"name\":\"Mitch Semienchuk\",\"sameAs\":[\"analytics\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Remplacement des dispositifs de reconstitution BAXJECT II \/ BAXJECT II Hi-Flow co-emball\u00e9s avec Advate\/Feiba\/Rixubis | FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/wfh.org\/fr\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/","og_locale":"fr_FR","og_type":"article","og_title":"Remplacement des dispositifs de reconstitution BAXJECT II \/ BAXJECT II Hi-Flow co-emball\u00e9s avec Advate\/Feiba\/Rixubis","og_description":"Takeda a pris la d\u00e9cision de remplacer les dispositifs de reconstitution BAXJECT II et BAXJECT II Hi-Flow, produits chez son fabricant sous-traitant entre octobre 2021 et 2022. Il s\u2019agit d\u2019une mesure de pr\u00e9caution due \u00e0 la pr\u00e9sence possible de particules au niveau du port Luer. Ce probl\u00e8me est li\u00e9 au dispositif lui-m\u00eame et aucun d\u00e9faut qualit\u00e9 n\u2019affecte le produit th\u00e9rapeutique ou tout autre composant de la bo\u00eete. Aucun effet ind\u00e9sirable signal\u00e9 dans la base de donn\u00e9es de s\u00e9curit\u00e9 de Takeda n\u2019est attribuable \u00e0 la pr\u00e9sence de particules dans les dispositifs BAXJECT II ou BAXJECT II Hi-Flow.","og_url":"https:\/\/wfh.org\/fr\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/","og_site_name":"FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie","article_publisher":"https:\/\/www.facebook.com\/wfhemophilia\/","article_published_time":"2023-08-17T17:47:27+00:00","article_modified_time":"2024-04-08T12:34:39+00:00","og_image":[{"width":2501,"height":1307,"url":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/12\/Medical-news-header-FR.gif","type":"image\/gif"}],"author":"Mitch Semienchuk","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Mitch Semienchuk","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/wfh.org\/fr\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/#article","isPartOf":{"@id":"https:\/\/wfh.org\/fr\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/"},"author":{"name":"Mitch Semienchuk","@id":"https:\/\/wfh.org\/fr\/#\/schema\/person\/f57928f0dd0ca8906b81082895256d8f"},"headline":"Remplacement des dispositifs de reconstitution BAXJECT II \/ BAXJECT II Hi-Flow co-emball\u00e9s avec Advate\/Feiba\/Rixubis","datePublished":"2023-08-17T17:47:27+00:00","dateModified":"2024-04-08T12:34:39+00:00","mainEntityOfPage":{"@id":"https:\/\/wfh.org\/fr\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/"},"wordCount":199,"publisher":{"@id":"https:\/\/wfh.org\/fr\/#organization"},"image":{"@id":"https:\/\/wfh.org\/fr\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/#primaryimage"},"thumbnailUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/12\/Medical-news-header-FR.gif","articleSection":["Actualit\u00e9 m\u00e9dicale"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/wfh.org\/fr\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/","url":"https:\/\/wfh.org\/fr\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/","name":"Remplacement des dispositifs de reconstitution BAXJECT II \/ BAXJECT II Hi-Flow co-emball\u00e9s avec Advate\/Feiba\/Rixubis | FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie","isPartOf":{"@id":"https:\/\/wfh.org\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/wfh.org\/fr\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/#primaryimage"},"image":{"@id":"https:\/\/wfh.org\/fr\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/#primaryimage"},"thumbnailUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/12\/Medical-news-header-FR.gif","datePublished":"2023-08-17T17:47:27+00:00","dateModified":"2024-04-08T12:34:39+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/wfh.org\/fr\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/wfh.org\/fr\/article\/remplacement-des-dispositifs-de-reconstitution-baxject-ii-baxject-ii-hi-flow-co-emballes-avec-advate-feiba-rixubis\/#primaryimage","url":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/12\/Medical-news-header-FR.gif","contentUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/12\/Medical-news-header-FR.gif","width":2501,"height":1307,"caption":"logo stock"},{"@type":"WebSite","@id":"https:\/\/wfh.org\/fr\/#website","url":"https:\/\/wfh.org\/fr\/","name":"FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie","description":"WFH - World Federation of Hemophilia","publisher":{"@id":"https:\/\/wfh.org\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/wfh.org\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/wfh.org\/fr\/#organization","name":"World Federation of Hemophilia","url":"https:\/\/wfh.org\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/wfh.org\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg","contentUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg","width":210,"height":63,"caption":"World Federation of Hemophilia"},"image":{"@id":"https:\/\/wfh.org\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/wfhemophilia\/"]},{"@type":"Person","@id":"https:\/\/wfh.org\/fr\/#\/schema\/person\/f57928f0dd0ca8906b81082895256d8f","name":"Mitch Semienchuk","sameAs":["analytics"]}]}},"_links":{"self":[{"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/posts\/83785"}],"collection":[{"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/comments?post=83785"}],"version-history":[{"count":3,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/posts\/83785\/revisions"}],"predecessor-version":[{"id":84340,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/posts\/83785\/revisions\/84340"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/media\/52730"}],"wp:attachment":[{"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/media?parent=83785"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/categories?post=83785"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/tags?post=83785"},{"taxonomy":"search-category","embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/search-category?post=83785"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}